Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Regeneron Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
REGN
Nasdaq
8731
https://www.regeneron.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Regeneron Pharmaceuticals Inc
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
- Mar 28th, 2024 12:33 pm
Stock-Split Watch: Are These 2 Top Growth Stocks Next?
- Mar 28th, 2024 12:00 pm
Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
- Mar 28th, 2024 5:00 am
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
- Mar 26th, 2024 2:37 pm
Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment?
- Mar 26th, 2024 11:00 am
FDA rejects Regeneron lymphoma drug, setting back company’s oncology push
- Mar 25th, 2024 11:55 am
UPDATE 3-Regeneron's blood cancer therapy faces setback as FDA raises trial concerns
- Mar 25th, 2024 11:27 am
Regeneron Provides Update on Biologics License Application for Odronextamab
- Mar 25th, 2024 11:00 am
US appeals court revives Regeneron's antitrust lawsuit against Novartis
- Mar 18th, 2024 5:28 pm
11 Oversold Biotech Stocks To Buy Right Now
- Mar 17th, 2024 9:20 pm
Regeneron Pharmaceuticals Insiders Sold US$26m Of Shares Suggesting Hesitancy
- Mar 17th, 2024 11:00 am
Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
- Mar 14th, 2024 12:08 pm
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
- Mar 13th, 2024 2:55 pm
High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
- Mar 13th, 2024 3:55 am
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
- Mar 12th, 2024 4:32 pm
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
- Mar 12th, 2024 1:58 pm
Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
- Mar 11th, 2024 11:00 am
Is There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 42% Undervaluation?
- Mar 9th, 2024 2:00 pm
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
- Mar 9th, 2024 10:52 am
2 Biotech Stocks to Buy Hand Over Fist in March
- Mar 8th, 2024 1:15 pm
Scroll